Microbiome Drugs Market Opportunities in Therapeutics
According to FutureWise analysis the market for microbiome drugs in 2026 is US$ 0.49 billion, and is expected to reach US$ 1.47 billion by 2036 at a CAGR of 11.61%. The growth in this field is driven by increased research into the human microbiome's role in chronic and metabolic diseases, along with rising investments in microbiome therapeutics and advancements in precision medicine. Growing...
0 Comments 0 Shares 194 Views 0 Reviews
Sponsored